Latest filing published 23 Apr 2026 for Day One Biopharmaceuticals, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Adam Dubow across 2 companies, led by Day One Biopharmaceuticals, Inc. and Bristol Myers Squibb Co. Over a trading history stretching from 5 May 2021 to 23 April 2026, the count stands at 13 filings.
Sales make up the whole of the open-market record (2 sales, €308k). Other entries cover 10 option exercises.
The newest entry dates from 23 April 2026: a transaction, in Day One Biopharmaceuticals, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations